Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.22M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$1.29M
-
Value change
-
-$1.77M
-
Put/Call ratio
-
0.25
-
Number of buys
-
12
-
Number of sells
-
-12
-
Price
-
$1.06
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q1 2022
38 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q1 2022.
Protalix BioTherapeutics, Inc. - COM (PLX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.22M shares
.
Largest 10 shareholders include MEITAV DASH INVESTMENTS LTD (244K shares), Phoenix Holdings Ltd. (244K shares), Spire Wealth Management (149K shares), JANE STREET GROUP, LLC (145K shares), BlackRock Inc. (109K shares), TWO SIGMA ADVISERS, LP (58.9K shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (41.6K shares), GROUP ONE TRADING, L.P. (32.6K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (28.8K shares), and IHT Wealth Management, LLC (24K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.